Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:abusePotential |
High
|
| gptkbp:administeredBy |
gptkb:DEA
|
| gptkbp:cause |
Severe psychological or physical dependence
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:dateEnacted |
1970
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:example |
gptkb:Cocaine
gptkb:Amphetamine gptkb:Dexmethylphenidate gptkb:Hydrocodone gptkb:Hydromorphone gptkb:Meperidine gptkb:Methylphenidate gptkb:Morphine gptkb:Oxycodone gptkb:Pentobarbital gptkb:Secobarbital gptkb:Tapentadol gptkb:Oxymorphone Methamphetamine Fentanyl Lisdexamfetamine |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule 2 (USA)
|
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:medicalUse |
gptkb:Accepted
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:prescriptionExpiration |
6 months
|
| gptkbp:refillsAllowed |
No
|
| gptkbp:regulates |
Drugs with high potential for abuse and accepted medical use
|
| gptkbp:requires |
Written prescription
|
| gptkbp:bfsParent |
gptkb:B.Z.
|
| gptkbp:bfsLayer |
7
|